Canadian Cancer Trials Group Bulletins

Trial Management Group

Recent Publication

Response Evaluation Criteria In Solid Tumours (RECIST) remain an integral part of the assessment of tumour burden in many clinical trials in oncology; these criteria are used to evaluate the activity and efficacy of new cancer therapeutics in solid tumours.

Litire S, Collette S, de Vries EGE, Seymour L, Bogaerts J. RECIST- learning from the past to build the future (ONLINE). Nat Rev Clin Oncol advance online publication: 2016.